Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.

Abstract

Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. When MRI demonstrates a uterine mass appearing as a heterogeneous mass in the endometrium or myometrium, adenofibroma and ECC must be considered as rare, but possible, diagnoses.

• Authors: Kazumasa Hayasaka, Kazuo Morita, Tomoya Saitoh, Yoshiaki Tanaka
• Journal: Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society (Comput Med Imaging Graph) Vol. 30 Issue 5 Pg. 315-8 (Jul 2006) ISSN: 0895-6111 [Print] United States
• PMID: 16890405 (Publication Type: Case Reports, Journal Article)

Chemical References

• Tamoxifen

Topics

• Adenofibroma (chemically induced, diagnosis)
• Aged
• Contraindications
• Female
• Humans
• Magnetic Resonance Imaging
• Sarcoma, Endometrial Stromal (chemically induced, diagnosis)
• Tamoxifen (administration & dosage)
• Uterine Neoplasms (chemically induced, diagnosis)